Hemoglobin A1c, body mass index, and the risk of hypertension in women

American Journal of Hypertension

Volumn 24, Issue 3, 2011, Pages 328-334

  Britton, Kathryn A ^a,b   Pradhan, Aruna D ^b   Gaziano, J Michael ^a,b   Manson, Joann E ^b,c   Ridker, Paul M ^a   Buring, Julie E ^b,c   Sesso, Howard D ^b,c  

^a Massachusetts Veterans Epidemiology   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

blood pressure; body mass index; diabetes; epidemiology; hypertension

Indexed keywords

HEMOGLOBIN A1C; HYPERTENSIVE AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; HAZARD RATIO; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; BODY MASS INDEX; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 79951675073     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.233     Document Type: Article

References (35)

1. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993; 11:309-317.
2. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:412-419. (Pubitemid 30609443)
3. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 2004; 286:H1597-H1602. (Pubitemid 38525443)
4. Vecchione C, Colella S, Fratta L, Gentile MT, Selvetella G, Frati G, Trimarco B, Lembo G. Impaired insulin-like growth factor I vasorelaxant effects in hypertension. Hypertension 2001; 37:1480-1485. (Pubitemid 34225395)
5. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/ insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.
6. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001; 37:1523-1528.
7. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, Mitchell GF, Sheffy J, Vita JA, Benjamin EJ. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117:2467-2474. (Pubitemid 351670453)
8. Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, Colditz GA. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998; 128:81-88. (Pubitemid 28053128)
9. Gelber R P, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007; 20:370-377. (Pubitemid 46441762)
10. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23:1170-1178.
11. Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 2009; 32:439-444.
12. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352:1293-1304.
13. Jones BR, Barrett-Connor E, Criqui MH, Holdbrook MJ. A community study of calorie and nutrient intake in drinkers and nondrinkers of alcohol. Am J Clin Nutr 1982; 35:135-139. (Pubitemid 12126598)
14. Rissanen AM, Heliövaara M, Knekt P, Reunanen A, Aromaa A. Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr 1991; 45:419-430.
15. Wannamethee SG, Shaper AG. Alcohol, body weight, and weight gain in middle-aged men. Am J Clin Nutr 2003; 77:1312-1317. (Pubitemid 44858451)
16. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986; 123:894-900. (Pubitemid 16049247)
17. Klag MJ, He J, Mead LA, Ford DE, Pearson TA, Levine DM. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol 1993; 3:442-447. (Pubitemid 23195832)
18. Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM. Alcohol consumption and the risk of hypertension in women and men. Hypertension 2008; 51:1080-1087. (Pubitemid 351398961)
19. Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW. Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabet Med 2005; 22:1726-1730. (Pubitemid 43046475)
20. Kristiansson K, Sigfusson N, Sigvaldason H, Thorgeirsson G. Glucose tolerance and blood pressure in a population-based cohort study of males and females: the Reykjavik Study. J Hypertens 1995; 13:581-586.
21. Haffner SM, Valdez R, Morales PA, Mitchell BD, Hazuda H P, Stern M P. Greater effect of glycemia on incidence of hypertension in women than in men. Diabetes Care 1992; 15:1277-1284.
22. Fagot-Campagna A, Balkau B, Simon D, Ducimetière P, Eschwège E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997; 26:542-550. (Pubitemid 27267775)
23. Esteghamati A, Khalilzadeh O, Abbasi M, Nakhjavani M, Novin L, Esteghamati AR. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects. Clin Exp Hypertens 2008; 30:297-307. (Pubitemid 352009291)
24. Goff DC Jr, Zaccaro DJ, Haffner SM, Saad MF; Insulin Resistance Atherosclerosis Study. Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2003; 26:805-809. (Pubitemid 36929347)
25. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41:202-208.
26. Chu NF, Lee MM, Wang DJ, Chen LM, Shieh SM. The reappraisal of the association of glycosylated hemoglobin A1c (HbA1c) and blood pressure: a hypertension and diabetes study in a Taiwan rural area. J Clin Epidemiol 1993; 46:173-179. (Pubitemid 23092126)
27. Kroke A, Liese AD, Keil U, Boeing H. Arterial hypertension and glycemia in non-diabetic subjects: is there an association independent of obesity? Diabetes Metab Res Rev 1999; 15:99-105. (Pubitemid 29253763)
28. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110:1245-1250. (Pubitemid 39202340)
29. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132:501-513. (Pubitemid 20285148)
30. Guilherme A, Virbasius JV, Puri V, Czech M P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377. (Pubitemid 351574198)
31. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 2005; 96:1042-1052. (Pubitemid 40791376)
32. Edens MA, Kuipers F, Stolk R P. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obes Rev 2009; 10:412-419.
33. Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich N, Gutiérrez-Ramos JC, Arroyo V, Rodés J. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 2003; 125:117-125. (Pubitemid 36799113)
34. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23:57-63. (Pubitemid 30022895)
35. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K. Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 1996; 45:242-256.